Watson raises $850 million for Arrow acquisition
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals is to raise an aggregate principal amount of $850 million through a registered public offering to help finance its $1.75 billion acquisition of the Arrow Group (scripnews.com, June 18th, 2009).